How To Get Affordable Glyxambi® Generic (Empagliflozin + Linagliptin) For Diabetes Globally

Summary - Glyxambi® (empagliflozin + linagliptin) helps control blood sugar in type 2 diabetes but costs $350 to $700 monthly in the US - with no generic available. MedsPartner offers quality-assured generic combination tablets at ~92% savings through compliant personal importation. This blog explains affordable access pathways.

Type 2 diabetes affects millions worldwide and requires consistent daily meds to prevent serious complications. Uncontrolled blood sugar damages blood vessels, nerves, kidneys, and eyes over time. But with proper treatment, people with type 2 diabetes can live normal, healthy lives.

Glyxambi® combines two proven diabetes medicines in one tablet - helping with effective blood sugar control. Yet high prices create barriers for many patients trying to maintain consistent treatment. No generic version exists in the US market yet - the patent protection keeps costs elevated. 

However, quality-assured generics from FDA/EMA-certified Indian manufacturers provide cost relief. MedsPartner connects patients across 45+ countries - from the USA and UK to Australia and New Zealand - with affordable generic empagliflozin + linagliptin. In this blog we look at how quality generics from MedsPartner can help you save thousands of dollars every year.

How does Glyxambi® treat type 2 diabetes?

Glyxambi® combines two diabetes medicines that work in complementary ways. Empagliflozin belongs to the SGLT2 inhibitor class. It works by helping the kidneys remove excess glucose through urine. When blood sugar is high, empagliflozin causes the kidneys to excrete more glucose rather than reabsorbing it back into the bloodstream.

Linagliptin belongs to the DPP-4 inhibitor class. It increases levels of incretin hormones in the body. These hormones help with insulin release when blood sugar rises and reduce glucose production by the liver. Together, these two mechanisms provide better blood sugar control than either medicine alone.

Recent updates on Glyxambi® generic availability and uses

Generic empagliflozin + linagliptin widely available internationally

Multiple manufacturers produce generic versions of this combination globally, particularly in India and other countries. However, no generic is available in the US market yet. Branded Glyxambi® maintains patent protection in the United States. Generics from Indian manufacturers offer substantially lower costs.

Glyxambi® recommended for dual-mechanism diabetes control

Treatment guidelines support combination therapy for type 2 diabetes when single medications don't achieve adequate control. Glyxambi® offers the ease of two medicines in one tablet, improving treatment adherence.

Glyxambi® cost - Why does branded pricing remain high?

Branded versions carry premium pricing due to development investments, combination therapy convenience, and patent protection. Patent-protected versions prevent entry of affordable variants.

No US generic exists yet, keeping domestic prices elevated. Insurance typically covers Glyxambi® but often requires prior authorization and carries substantial copays for specialty combination medications. Many patients face hundreds in monthly out-of-pocket costs despite coverage.

Generic manufacturers in countries like India produce this combination at substantially lower costs. MedsPartner works with FDA/EMA-approved manufacturers in India to source affordable generic empagliflozin + linagliptin. These generics provide the same active ingredients and comparable benefits at a fraction of US prices.

How much can I save by switching to generic Glyxambi® from MedsPartner?

At standard dosing of one tablet daily, patients need 30 tablets monthly. Branded Glyxambi® costs approximately $350 per month in the US. No generic alternative exists domestically. In comparison, MedsPartner's generic costs $88 for 90 tablets - which works out to about $30 per month. This means savings of ~92% compared to branded versions - that's around $320 in monthly savings. The result - almost $4K saved per year.

Is personal import of Glyxambi® generic legal?

Yes - many countries allow patients to import prescription meds in limited quantities for serious conditions like diabetes when local options are too expensive or unavailable. The rules vary by country, but often require a valid prescription from your doctor, declaration of personal use, and quantities limited to 1-3 months of meds.

MedsPartner has managed compliant personal imports for over 9 years, delivering to patients in more than 45 countries. We handle the required paperwork for each destination - whether USA, UK, Australia, New Zealand, or others. Our track record includes 30,000+ successful deliveries for diabetes and other essential medicines. Our process starts by helping you understand personal import rules in your country, then processing your order in full compliance with your local regulations.

How a diabetes patient in Colombia accessed affordable treatment

Maria was diagnosed with type 2 diabetes five years ago. Her doctor prescribed Glyxambi® after other medications didn't achieve adequate blood sugar control. The combination worked well for managing her condition.

In Colombia, while branded Glyxambi® is available through some pharmacies, consistent supply and high costs created barriers. The local price strained her budget significantly.

Maria looked for access options and found MedsPartner online. With a valid prescription and medical records, she was able to access quality-assured generic empagliflozin + linagliptin through MedsPartner.

The affordable generic allowed her to stay on her prescribed treatment without steep costs.

This is one of many such patient stories from around the world. We are glad to support patients in 45+ countries with essential medicines when local options run out.

Your questions about Glyxambi® price and access answered

Q1. How can I trust MedsPartner's generic Glyxambi® quality?

A - MedsPartner sources generic empagliflozin + linagliptin exclusively from an FDA/EMA-approved manufacturer in India. These generics have the same active ingredients and proven similar benefits as the branded medicine. Plus, we provide complete manufacturer details and expiry dates with every order, so you know exactly where your medicine comes from. Our 9-year track record includes 30,000+ successful deliveries across 45+ countries - including USA, UK, NZ, and Australia. Our 4.7-star rating on TrustPilot also speaks of our quality.

Q2. What if insurance denies coverage for Glyxambi® or copay is too high?

A - If insurance denies your claim, have your doctor submit an appeal with detailed medical documentation explaining why this combination therapy is medically necessary for your diabetes control. Boehringer Ingelheim runs patient assistance programs that may help eligible patients - check their website for current enrollment criteria. For patients facing unmanageable costs despite these options, generic empagliflozin + linagliptin through MedsPartner's compliant importation program offers ~92% savings compared to US pricing.

Q3. How does ordering generic Glyxambi® work with MedsPartner?

A - Visit MedsPartner's empagliflozin + linagliptin product page and upload your prescription without payment. Our team verifies prescription validity and checks your country's importation regulations. We inform you about your country's personal import rules and then provide final pricing with shipping costs. After you confirm and pay, we handle all customs documentation and ship via international carriers following your country’s rules.

Q4. I'm a doctor - how can I help my patient access affordable Glyxambi®?

A - Email support@medspartner.com with patient information and prescription. We work directly with patients and their families to arrange compliant personal importation to their doorstep. We will get in touch with your patient to initiate the same.

Q5. What are the common side effects of Glyxambi®?

A - The most common side effects of Glyxambi® include urinary tract infections, which occur more frequently due to empagliflozin increasing glucose in urine. Yeast infections may also occur for similar reasons. Upper respiratory infections and nasopharyngitis are commonly reported. Some patients experience increased urination, especially when first starting treatment. Rare but serious side effects include diabetic ketoacidosis (even with normal blood sugar), kidney problems, and severe urinary tract infections. Dehydration and low blood pressure can occur, particularly in elderly patients. Your doctor will help you monitor and manage these side effects.

Q6. What savings can I expect switching to MedsPartner's generic?

A - At standard dosing of one tablet daily (30 tablets monthly), branded Glyxambi® costs approximately $350 per month. MedsPartner's generic Glyxambi alternative costs $88 for 90 tablets, which is about $30 per month. That's around $320 in monthly savings - a 92% cost reduction. Since diabetes treatment is lifelong - these savings add up to thousands of dollars per year.

Affordable diabetes treatment makes a difference

Glyxambi® has helped countless diabetes patients achieve better blood sugar control. Yet monthly bills exceeding $350 are a barrier to essential treatment. Some patients switch to less effective medicines or skip doses to save money which can be dangerous when dealing with something as serious as diabetes.

MedsPartner removes that barrier by connecting patients with quality-certified generic empagliflozin + linagliptin priced to fit realistic budgets. We've helped thousands of diabetes patients maintain uninterrupted access to their medicines without financial stress.

Need help accessing affordable Glyxambi®? Get in touch at support@medspartner.com or place your order directly. We help you access the diabetes treatment your doctor prescribed at prices that won't strain your budget.

About The Author - Aayyush Goyal has a background in healthcare consulting and pharmaceutical supply chains - with over a decade of experience in drug pricing, regulatory policy & patient rights. He has advised patients, advocacy groups & healthcare providers across 40+ countries on safe and compliant access to essential medicines. Through MedsPartner - Aayyush has overseen more than 30,000 successful patient deliveries worldwide - ensuring affordability without compromising safety or legality. He is a recognized advocate for ethical sourcing, generic access & cross-border care solutions and has contributed insights on global drug access in healthcare forums, media publications, and patient support networks.